Quotes

Back To Menu

UTI-Healthcare Fund (G) Equity - Pharma
INVEST

Plan: OPEN | Option: Growth | Kamal Gada

25 Oct 24 | 12:00 AM

277.57 -1.48 (-0.53%)

  • Outperforms

    54.74%

    Return (1Y)

    beaten BSE Healthcare TRI by 6.42%

  • Less Volatile

    0.75%

    Standard Deviation (1Y)

    Lower Equity - Pharma by -0.20%

  • Inconsistent

    1/6

    Months

    Has underperformed Equity - Pharma

  • Value research rating

    Not Rated

Stock Composition

NAV

Scheme Trivia

  • UTI-Pharma & Healthcare Fund (G) fund has been the 5th best in 5Y performance in the Equity - Pharma category

  • UTI-Pharma & Healthcare Fund (G) fund has been given the 4th best Risk adjusted performance for the past 5Y in the Equity - Pharma category

  • UTI-Pharma & Healthcare Fund (G) fund has been the 5th best in the 5Y SIP performance in the Equity - Pharma category

Critical Parameters

Everyone of us wants to create wealth by investing in top funds. Have a look at the key parameters that you need to check before deciding to invest in a mutual fund.

Returns

In last 1 year UTI-Healthcare Fund (G), has underperformed by 6.42% (CAGR difference)

54.74%

Outperforms

This is Alpha

Performance Chart for Rs

Invested in

09 Nov 2023

Risk

In last 1 year , the volatility of UTI-Healthcare Fund (G) is Lower than by -0.20%

0.75%

Less Volatile

Risk Meter

Peer Comparison on Risk - Return

Consistency

For 1 out of Last 6 Months, i.e 16.67% of the times It underperformed its benchmark, Equity - Pharma

Consistency Meter

Outperforming Stocks Vs. Underperforming Stocks

Based on the last 1year analysis, currently there are, the benchmark the benchmark

View Stock Composition